Realm Therapeutics has, pending shareholder approval, agreed to be acquired by ESSA Pharma.
ESSA’s unattractive bid is in illiquid stock and strongly undervalues Realm’s cash position.
Realm’s board and large shareholders clearly have a… Read more
Thanks to a small float and an ongoing stock promotion Eco Science Solutions has been up over 700% over the last twelve months.
Today, however, the size of its float has exploded overnight as… Read more
Marijuana stocks have been on fire these last few weeks in anticipation of Tuesday’s marijuana vote;
Cannabis Sativa is up 800% this year and now has over a 100M market cap;
However, the company… Read more
Last Friday MGT Capital filed its long awaited proxy statement with details on the proposed appointment of John McAfee as its new CEO.
Proposals with regards to recent acquisitions as well as a stock… Read more
Shares in shipper PRGN rallied over 500% in the last seven trading days.
However, the company recently sold all of its assets to pay down debt and has very little cash left.
Even PRGN’s… Read more
EBIO’s main drug failed two Phase 3 studies in a row.
However, last month its share price rose 300% on speculation the drug might work after all.
Yesterday EBIO squashed these rumors confirming the… Read more
DARA is planning to be acquired by UK-listed Midatech Pharma.
Midatech’s offer to DARA shareholders consists of ADRs as well as a CVR based on certain milestones.
After the deal is completed Midatech’s ADRs… Read more
The share price of troubled bio-tech KBIO exploded last week after Martin Shkreli bought a majority stake.
Shkreli was appointed CEO and secured 13 million dollar in financing.
Shkreli bought KBIO because of a… Read more
EURI has seen unusual high trading activity as a result of a big (ongoing) stock promotion this month.
This tiny company with minimal revenue now has a market cap of over 130 million dollar.… Read more
* Ten OTC-listed stocks appear independent, but are run by a small group of insiders.
* These insiders net millions on convertible debt conversion at the expense of shareholders.
* CEOs appear to be… Read more